Change over period: —
NSE · MADHAVBAUG
Vaidya Sane Ayurved Laboratories Ltd
Produces Ayurvedic medicines and herbal products. Revenue comes from B2B and retail sales. Focuses on natural sourcing, quality, and regulatory compliance. Operates manufacturing and retail distribution model.
The short version. Return on equity was 12.5% in Mar 2026. Promoter holding was 66.34% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
2 · The business
Is it growing?
Reported results · ₹ crore
Revenue and profit
Show the numbers
Annual
| FY2026 | FY2025 | |
|---|---|---|
| Revenue | 107 | 90 |
| Net profit | 9 | 7 |
| Net margin % | 8.4 | 8.0 |
| EPS (₹) | 8.55 | 6.82 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 12.5% in Mar 2026; debt to equity is 0.04.
Profitability · 2 years
Returns and margins
| Mar 2026 | Mar 2025 | |
|---|---|---|
| Return on equity % | 12.5 | 11.5 |
| Return on capital % | 12.5 | 15.3 |
| EBITDA margin % | 16.3 | 15.4 |
| Net margin % | 8.2 | 7.8 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | — | — |
| Profit CAGR | — | — |
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 66.34 | 66.34 | 66.34 | 66.34 | 66.34 | 66.34 | 66.34 | 66.34 | 0.0 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0.21 | 0 | 0 | 0 | 0 |
| Public | 33.66 | 33.66 | 33.66 | 33.66 | 33.45 | 33.66 | 33.66 | 33.66 | 0.0 |
Mutual fund holdings · Oct 2026
0 schemes hold this stock
0 the month before.
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for Vaidya Sane Ayurved Laboratories Ltd are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Healthcare Equipment & Supplies stocks
Quick answers
Common questions about Vaidya Sane Ayurved Laboratories Ltd
What is the Vaidya Sane Ayurved Laboratories Ltd share price?
Vaidya Sane Ayurved Laboratories Ltd (MADHAVBAUG) last closed at ₹162.50, up 0.0% on the day.
What is the market cap of Vaidya Sane Ayurved Laboratories Ltd?
Vaidya Sane Ayurved Laboratories Ltd has a market capitalisation of about ₹170 crore. Its price-to-earnings ratio is 19.1.
How are Vaidya Sane Ayurved Laboratories Ltd's latest results?
Return on equity was 12.5% in Mar 2026. Promoter holding was 66.34% in Sep 2026, up 0.00 points over 8 quarters.
Who owns Vaidya Sane Ayurved Laboratories Ltd?
As of Sep 2026, shareholding was: Promoter 66.34%, Public 33.66%.
How many mutual funds hold Vaidya Sane Ayurved Laboratories Ltd?
0 mutual fund schemes held Vaidya Sane Ayurved Laboratories Ltd in October 2026. That compares with 0 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 05 Sep 2023 · Dividend - Rs. 0.25
- 18 Nov 2022 · Interim Dividend - Rs. 0.25
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.